GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
Quote as of Aug 26, 2026 19:59 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 90.95 | Day Range | 90.69 – 91.15 |
| 52-Week Range | 70.21 – 92.84 | Volume | 21.79K |
| Avg Volume | 36.20K | AUM | $1.10B (Aug 27, 2026) |
| Expense Ratio | 0.20% | Yield (TTM) | 1.03% |
| NAV | 91.01 | Premium/Discount | -0.05% indicative |
| Inception | Jun 28, 2017 | Holdings | 1364 |
| Issuer | Goldman | Exchange | AMEX |
| Category | Us Small Cap | Index Tracked | Not stated in source data |
| CUSIP | 381430602 | ISIN | US3814306029 |
| Management | Not stated in source data | ||
About this ETF
This ETF aims to replicate the investment returns generated by the Goldman Sachs ActiveBeta U.S. Small Cap Equity Index.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +2.38% | +5.68% | +15.17% | +20.26% | +23.54% | +16.48% | +7.47% | — | +9.35% |
| Total return | +2.38% | +5.93% | +15.76% | +20.86% | +25.00% | +18.01% | +8.91% | — | +10.72% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.20% | Annual cost of a $10,000 investment | $20.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 1418 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | CMRC/CME EMINIRUS2K 9/2026 | — | 1.26% | 92 | $13.8M |
| 2 | 10X GENOMICS INC | TXG | 0.50% | 84.94K | $5.4M |
| 3 | ENOVA INTERNATIONAL, INC. | ENVA | 0.40% | 17.70K | $4.4M |
| 4 | ALKERMES PLC | ALKS | 0.39% | 86.35K | $4.2M |
| 5 | CAREDX, INC. | CDNA | 0.38% | 87.45K | $4.2M |
| 6 | TRAVERE THERAPEUTICS, INC. | TVTX | 0.37% | 61.19K | $4.0M |
| 7 | ACADIAN ASSET MANAGEMENT INC | AAMI | 0.33% | 39.21K | $3.6M |
| 8 | DAVE INC. | DAVE | 0.29% | 9.03K | $3.2M |
| 9 | STONEX GROUP INC. | SNEX | 0.29% | 46.41K | $3.1M |
| 10 | ACADIA PHARMACEUTICALS, INC. | ACAD | 0.28% | 104.59K | $3.1M |
| 11 | ZETA GLOBAL HOLDINGS CORP. | ZETA | 0.28% | 107.84K | $3.1M |
| 12 | ATRICURE, INC | ATRC | 0.27% | 59.91K | $3.0M |
| 13 | VICTORIA'S SECRET & COMPANY | VSXY | 0.27% | 33.29K | $2.9M |
| 14 | UNITED NATURAL FOODS INC | UNFI | 0.26% | 58.53K | $2.8M |
| 15 | VIASAT, INC | VSAT | 0.25% | 38.45K | $2.8M |
| 16 | TG THERAPEUTICS, INC. | TGTX | 0.25% | 49.61K | $2.8M |
| 17 | COMPASS, INC. | COMP | 0.25% | 234.14K | $2.7M |
| 18 | UMB FINANCIAL CORP | UMBF | 0.25% | 18.73K | $2.7M |
| 19 | APPIAN CORPORATION | APPN | 0.24% | 68.07K | $2.7M |
| 20 | ENERSYS | ENS | 0.24% | 13.85K | $2.6M |
| 21 | AMNEAL NEWCO INC. | AMRX | 0.23% | 143.44K | $2.6M |
| 22 | GRIFFON CORPORATION | GFF | 0.23% | 25.09K | $2.5M |
| 23 | PTC THERAPEUTICS, INC. | PTCT | 0.23% | 35.59K | $2.5M |
| 24 | DXP ENTERPRISES INC | DXPE | 0.23% | 13.49K | $2.5M |
| 25 | LIGAND PHARMACEUTICALS INCORPORATED | LGND | 0.23% | 8.97K | $2.5M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.03% | Paid (last 12 months) | $0.9377 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 24, 2026 | Last payment | $0.2142 (Jun 30, 2026) |
| Growth 1Y | +1.55% | Growth 3Y / 5Y (ann.) | +5.30% / +14.43% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 24, 2026 | Jun 24, 2026 | Jun 30, 2026 | $0.2142 |
| Mar 25, 2026 | Mar 25, 2026 | Mar 31, 2026 | $0.2049 |
| Dec 23, 2025 | Dec 23, 2025 | Dec 30, 2025 | $0.2474 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 30, 2025 | $0.2712 |
| Jun 24, 2025 | Jun 24, 2025 | Jun 30, 2025 | $0.1943 |
| Mar 25, 2025 | Mar 25, 2025 | Mar 31, 2025 | $0.1755 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 30, 2024 | $0.4371 |
| Sep 24, 2024 | Sep 24, 2024 | Sep 30, 2024 | $0.1164 |
| Jun 24, 2024 | Jun 24, 2024 | Jun 28, 2024 | $0.2301 |
| Mar 22, 2024 | Mar 25, 2024 | Mar 28, 2024 | $0.1959 |
| Dec 26, 2023 | Dec 27, 2023 | Jan 02, 2024 | $0.3146 |
| Sep 25, 2023 | Sep 26, 2023 | Sep 29, 2023 | $0.1180 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 17.82% / 20.43% | Sharpe 1Y / 3Y | 1.31 / 0.827 |
| Max drawdown 1Y / 3Y | -10.56% / -26.05% | Sortino 1Y | 2.00 |
| Beta vs S&P 500 (3Y) | 1.05 | Correlation vs S&P 500 (1Y) | 0.8 |
| Downside deviation 1Y | 11.72% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 21.79K | Average volume | 36.20K |
| AUM | $1.10B | Premium/Discount | -0.05% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $1.5M | +0.14% | $1.09B → $1.09B |
| 1 Week | -$5.6M | -0.51% | $1.11B → $1.09B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for GSSC
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.